Navigation Links
NeurogesX Appoints New Director to the Board
Date:9/5/2007

SAN CARLOS, Calif., Sept. 5 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing novel pain management therapies, announced today the appointment of Bruce A. Peacock to the NeurogesX board of directors. Since May 2006, Mr. Peacock has been a venture partner with SV Life Sciences, LLC.

Prior to joining SV Life Sciences, Mr. Peacock held senior executive positions with a number of biotechnology, medical device, and service organizations focused on healthcare. Most recently, Mr. Peacock was CEO of The Little Clinic, a start-up medical care services company. Prior to that, Mr. Peacock served as President and Chief Executive Officer and as a director of Adolor Corporation, President, CEO, COO and as a director of Orthovita, Inc., Executive Vice President, Chief Operating Officer and as a director of Cephalon, Inc., and Senior Vice President and CFO of Centocor, Inc. He currently serves as a member of the board of directors of Pharmacopeia, Inc., a publicly-held small molecule therapeutics company, as well as several private biotechnology companies.

Jean-Jacques Bienaime, Chairman of the NeurogesX board of directors, commented, "I am pleased to welcome Bruce Peacock to our board. Bruce is a seasoned pharmaceutical and biotechnology industry executive with a breadth of knowledge that will be very helpful to us as we continue on our strategic path. We believe that his operational and financial expertise as well as his business development and commercialization experience will be invaluable to us as we continue our efforts towards potential commercialization of our lead product candidate NGX-4010."

Mr. Peacock remarked, "NeurogesX is at an exciting point
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...FirstCall/ -- Eli Lilly and,Company (NYSE: LLY ) ...ion,of SGX Pharmaceuticals, Inc. (Nasdaq: SGXP ),...n drug discovery and development in the area,of on...s Special,Stockholders Meeting, in which a majorit... agreement with Lilly. Under the agreement, Lilly ...
(Date:8/20/2008)... and Caregivers, Grassroots ...ewswire-USNewswire/ -- Inc. Magazine has,named Sen...an for,low-income seniors, the number one fastest-...rt of Inc.,s annual list of the country,s 500 fast...1,000 percent from 2004 to 2007., "This is a rewa...
(Date:8/20/2008)...ll/ -- CEL-SCI CORPORATION,(Amex: CVM ) reports f...ing,June 30, 2008., The Company,s loss from opera...76,679 versus a loss of $3,776,263 during the same...ns for the nine months ended June 30, 2008,was $7,...e nine months in,2007., The net loss per common s...
(Date:8/20/2008).../ -- Huifeng Bio-Pharmaceutical,Technology, Inc (O...producer of plant extracts and pharmaceutical raw ... and food production, today announced it will,be i... August 19-21 in Rio,de Janeiro, Brazil., "Unpara...volved in the,pharmaceutical raw materials industr...
Breaking Biology Technology:Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 2CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 3CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 4CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 5Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil 2
...e announced on Monday that for the second year in...e application in the KLAS rankings of health inf...-year rankings API received the highest possible d...en 15 and 20 percent higher than its competitors i...nstrating an overall 3 percent increase from last ...
...umn, I raised the premise that in the early years ...roviding radically new solutions to health care. ,...k n roll where it was also not about making money ...(without getting jailed for it). Today, both busin...ustries that have become mainstream. , ,While the...
...t Chicago, with the assistance of GE Healthcare ...agnetic resonance imaging scanner, officials annou...nternal anatomy and brain functions in a non-invas...is a unit of magnetic strength. The magnet used in...he strength of the Earths magnetic field. , ,While...
... science is revolutionizing technology, and the Un...han $13 million to harness its potential during th...nology, is the study of materials and processes at...e under the lens of almost any microscope. These m...ith a single unit equal to one billionth of a mete...
Other Biology Technology:API Software best in health-care customer satisfaction, says KLAS report 2Biotech IPOs bring in encouraging sums 2Biotech IPOs bring in encouraging sums 3UW-Madison gets $13 million to study nanotech 2
(Date:8/20/2008)...ily of biodegradable polymers called polyketals an... inflammatory illnesses as acute lung injury, acut...delivering drugs, proteins and snips of ribonuclei...polyketal microparticles we developed are simply a...iseased area as quickly as possible," said Niren M...
(Date:8/20/2008)...LUMBUS, Ohio -- Researchers here have found a way ...n very efficiently. , A new catalyst makes hydro...ble temperature, and using inexpensive ingredients...ecular engineering at Ohio State University, said ...others being developed around the world, because i...
(Date:8/19/2008)..., Aug. 19, 2008 We all understand that even the t...pportunities and challenges for plants, animals an...ng on a microscopic level and what those changes c...rth or how mankind,s day-to-day experiences could...rchers Yuriy Fofanov and Lennart Johnsson understa...
(Date:8/19/2008)..., WI, August 18, 2008 -- Like most things that exi...asily forgotten, but while flowers, leaves, and ot...nt roots are equally deserving of our appreciation...zling ornamental lies a root system that makes it ... plants, extract water and nutrients from soil, an...
Breaking Biology News(10 mins):Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 3A better way to make hydrogen from biofuels 2A better way to make hydrogen from biofuels 3UH researchers win top prize for research with humanitarian applications 2UH researchers win top prize for research with humanitarian applications 3Getting to the root of the matter 2American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children wit 3497 1American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children wit 3497 2American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children wit 3497 3American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children wit 3497 4American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children wit 3497 5Survey Sees Mass CEOs as Bullish on Own Businesses 1218 1Survey Sees Mass CEOs as Bullish on Own Businesses 1218 2New membrane strips carbon dioxide from natural gas faster and better 766 1New membrane strips carbon dioxide from natural gas faster and better 766 2New membrane strips carbon dioxide from natural gas faster and better 766 3AIDS Drugs May Protect Brain 3493 1AIDS Drugs May Protect Brain 3493 2
...earchers have found that the cause of chronic sinu...- not in the nasal and sinus tissue targeted by st...n the August issue of Journal of Allergy and Clini... strikingly teaches against what has been thought ...ion: that inflammatory cells break down, releasing...
...r manipulating macromolecules has been developed b...ana-Champaign. The technique uses double-stranded ...In previous DNA nanotechnology efforts, duplex DNA...ometrical objects in three dimensions. Instead of ...rchers are using DNA to control the folding and re...
...r manipulating macromolecules has been developed b...ana-Champaign. The technique uses double-stranded ...In previous DNA nanotechnology efforts, duplex DNA...ometrical objects in three dimensions. Instead of ...rchers are using DNA to control the folding and re...
...ldren could be saved if $5.1 billion in new resour...ere provided each year, according to researchers f...ealth and other institutions. Approximately 90 per...und the world. In those countries, the average cos...a. With the recent publication of the potential im...
Other Biology News:Chronic Sinus Infection Thought To Be Tissue Issue, Mayo Clinic Scientists Show It's Snot 2UN successfully tests 'green' pesticide against locusts 2DNA constraints control structure of attached macromolecules 2$5.1 billion would save 6 million children 2$5.1 billion would save 6 million children 3
ANXA11 Immunogen: ANXA11 (NP_001148, 406 a.a. ~ 506 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only
Anti-Flavocytochrome b Monoclonal, FITC Labeled Research Focus: other Storage: 4C Shipping Temperature: 4C
Rabbit polyclonal to MKK6 (phospho S207) ( Abpromise for all tested applications). Antigen: Synthetic phosphopeptide derived from human MKK6 around the phosphorylation site of Serine 207 (V-D-S
Mouse monoclonal [1Q17] to TGE Virus peplomer ( Abpromise for all tested applications).
Biology Products: